Recital 4, Regulation (EU) 2020/2104

In forcesince 15 Dec 2020

Due to the fact that the assessment of the substance has been delayed for reasons beyond the control of the applicants, the approval of the active substance is likely to expire before a decision is taken on its renewal. It is therefore necessary to extend the approval period by one year.